These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 25201778)

  • 21. CNP and DPYSL2 mRNA expression and promoter methylation levels in brain of Alzheimer's disease patients.
    Silva PN; Furuya TK; Sampaio Braga I; Rasmussen LT; de Labio RW; Bertolucci PH; Chen ES; Turecki G; Mechawar N; Payão SL; Mill J; Smith MC
    J Alzheimers Dis; 2013; 33(2):349-55. PubMed ID: 22954668
    [TBL] [Abstract][Full Text] [Related]  

  • 22. D10S1423 identifies a susceptibility locus for Alzheimer's disease in a prospective, longitudinal, double-blind study of asymptomatic individuals.
    Zubenko GS; Hughes HB; Stiffler JS
    Mol Psychiatry; 2001 Jul; 6(4):413-9. PubMed ID: 11443525
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evolution of blood pressure in patients with Alzheimer's disease: a one year survey of a French Cohort (REAL.FR).
    Hanon O; Latour F; Seux ML; Lenoir H; Forette F; Rigaud AS;
    J Nutr Health Aging; 2005; 9(2):106-11. PubMed ID: 15791354
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A novel blood test for the early detection of Alzheimer's disease.
    Rye PD; Booij BB; Grave G; Lindahl T; Kristiansen L; Andersen HM; Horndalsveen PO; Nygaard HA; Naik M; Hoprekstad D; Wetterberg P; Nilsson C; Aarsland D; Sharma P; Lönneborg A
    J Alzheimers Dis; 2011; 23(1):121-9. PubMed ID: 20930265
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Kinesin gene variability may affect tau phosphorylation in early Alzheimer's disease.
    Andersson ME; Sjölander A; Andreasen N; Minthon L; Hansson O; Bogdanovic N; Jern C; Jood K; Wallin A; Blennow K; Zetterberg H
    Int J Mol Med; 2007 Aug; 20(2):233-9. PubMed ID: 17611642
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reduced CSF PLTP activity in Alzheimer's disease and other neurologic diseases; PLTP induces ApoE secretion in primary human astrocytes in vitro.
    Vuletic S; Peskind ER; Marcovina SM; Quinn JF; Cheung MC; Kennedy H; Kaye JA; Jin LW; Albers JJ
    J Neurosci Res; 2005 May; 80(3):406-13. PubMed ID: 15795933
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A TOMM40 poly-T variant modulates gene expression and is associated with vocabulary ability and decline in nonpathologic aging.
    Payton A; Sindrewicz P; Pessoa V; Platt H; Horan M; Ollier W; Bubb VJ; Pendleton N; Quinn JP
    Neurobiol Aging; 2016 Mar; 39():217.e1-7. PubMed ID: 26742953
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Isotyping the human TOMM40 variable-length polymorphism by gene amplification and restriction digest.
    Greco SJ; Hamzelou A; Johnston JM; Richardson S; Smith MA; Perry G; Ashford JW; Tezapsidis N
    Curr Alzheimer Res; 2012 Dec; 9(10):1168-73. PubMed ID: 22950840
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Commentary on 'Functional analysis of APOE locus genetic variation implicates regional enhancers in the regulation of both TOMM40 and APOE'.
    Carrasquillo MM; Morgan K
    J Hum Genet; 2012 Jan; 57(1):3-4. PubMed ID: 22158426
    [No Abstract]   [Full Text] [Related]  

  • 30. Investigation of
    Hajilou R; Farhud DD; Zarif-Yeganeh M
    Iran J Public Health; 2024 Mar; 53(3):663-670. PubMed ID: 38919296
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Broad Impact of TOM40 on Neurodegenerative Diseases in Aging.
    Gottschalk WK; Lutz MW; He YT; Saunders AM; Burns DK; Roses AD; Chiba-Falek O
    J Parkinsons Dis Alzheimers Dis; 2014 Nov; 1(1):. PubMed ID: 25745640
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of TOMM40 poly-T repeat lengths on age of onset and cerebrospinal fluid biomarkers in Finnish Alzheimer's disease patients.
    Helisalmi S; Hall A; Meriläinen EH; Väisänen V; Koivisto AM; Herukka SK; Laitinen M; Soininen H; Hiltunen M
    Neurodegener Dis; 2014; 14(4):204-8. PubMed ID: 25500937
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genetic contributions to variation in general cognitive function: a meta-analysis of genome-wide association studies in the CHARGE consortium (N=53949).
    Davies G; Armstrong N; Bis JC; Bressler J; Chouraki V; Giddaluru S; Hofer E; Ibrahim-Verbaas CA; Kirin M; Lahti J; van der Lee SJ; Le Hellard S; Liu T; Marioni RE; Oldmeadow C; Postmus I; Smith AV; Smith JA; Thalamuthu A; Thomson R; Vitart V; Wang J; Yu L; Zgaga L; Zhao W; Boxall R; Harris SE; Hill WD; Liewald DC; Luciano M; Adams H; Ames D; Amin N; Amouyel P; Assareh AA; Au R; Becker JT; Beiser A; Berr C; Bertram L; Boerwinkle E; Buckley BM; Campbell H; Corley J; De Jager PL; Dufouil C; Eriksson JG; Espeseth T; Faul JD; Ford I; ; Gottesman RF; Griswold ME; Gudnason V; Harris TB; Heiss G; Hofman A; Holliday EG; Huffman J; Kardia SL; Kochan N; Knopman DS; Kwok JB; Lambert JC; Lee T; Li G; Li SC; Loitfelder M; Lopez OL; Lundervold AJ; Lundqvist A; Mather KA; Mirza SS; Nyberg L; Oostra BA; Palotie A; Papenberg G; Pattie A; Petrovic K; Polasek O; Psaty BM; Redmond P; Reppermund S; Rotter JI; Schmidt H; Schuur M; Schofield PW; Scott RJ; Steen VM; Stott DJ; van Swieten JC; Taylor KD; Trollor J; Trompet S; Uitterlinden AG; Weinstein G; Widen E; Windham BG; Jukema JW; Wright AF; Wright MJ; Yang Q; Amieva H; Attia JR; Bennett DA; Brodaty H; de Craen AJ; Hayward C; Ikram MA; Lindenberger U; Nilsson LG; Porteous DJ; Räikkönen K; Reinvang I; Rudan I; Sachdev PS; Schmidt R; Schofield PR; Srikanth V; Starr JM; Turner ST; Weir DR; Wilson JF; van Duijn C; Launer L; Fitzpatrick AL; Seshadri S; Mosley TH; Deary IJ
    Mol Psychiatry; 2015 Feb; 20(2):183-92. PubMed ID: 25644384
    [TBL] [Abstract][Full Text] [Related]  

  • 34. APOE ε4: the most prevalent yet understudied risk factor for Alzheimer's disease.
    Michaelson DM
    Alzheimers Dement; 2014 Nov; 10(6):861-8. PubMed ID: 25217293
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genetic heterogeneity in Alzheimer disease and implications for treatment strategies.
    Ringman JM; Goate A; Masters CL; Cairns NJ; Danek A; Graff-Radford N; Ghetti B; Morris JC;
    Curr Neurol Neurosci Rep; 2014 Nov; 14(11):499. PubMed ID: 25217249
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nonlinear Association Between Cerebrospinal Fluid and Florbetapir F-18 β-Amyloid Measures Across the Spectrum of Alzheimer Disease.
    Toledo JB; Bjerke M; Da X; Landau SM; Foster NL; Jagust W; Jack C; Weiner M; Davatzikos C; Shaw LM; Trojanowski JQ;
    JAMA Neurol; 2015 May; 72(5):571-81. PubMed ID: 25822737
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Are APOE ɛ genotype and TOMM40 poly-T repeat length associations with cognitive ageing mediated by brain white matter tract integrity?
    Lyall DM; Harris SE; Bastin ME; Muñoz Maniega S; Murray C; Lutz MW; Saunders AM; Roses AD; Valdés Hernández Mdel C; Royle NA; Starr JM; Porteous DJ; Wardlaw JM; Deary IJ
    Transl Psychiatry; 2014 Sep; 4(9):e449. PubMed ID: 25247594
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Exosome mediated Tom40 delivery protects against hydrogen peroxide-induced oxidative stress by regulating mitochondrial function.
    Sayeed N; Sugaya K
    PLoS One; 2022; 17(8):e0272511. PubMed ID: 35951602
    [TBL] [Abstract][Full Text] [Related]  

  • 39.
    Lee EG; Chen S; Leong L; Tulloch J; Yu CE
    Genes (Basel); 2021 Jun; 12(6):. PubMed ID: 34204109
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prediction of Alzheimer's Disease-Associated Genes by Integration of GWAS Summary Data and Expression Data.
    Hao S; Wang R; Zhang Y; Zhan H
    Front Genet; 2018; 9():653. PubMed ID: 30666269
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.